CN1546158A - Specific medicine for treating cancer and preparing process - Google Patents
Specific medicine for treating cancer and preparing process Download PDFInfo
- Publication number
- CN1546158A CN1546158A CNA2003101213863A CN200310121386A CN1546158A CN 1546158 A CN1546158 A CN 1546158A CN A2003101213863 A CNA2003101213863 A CN A2003101213863A CN 200310121386 A CN200310121386 A CN 200310121386A CN 1546158 A CN1546158 A CN 1546158A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- herba
- medicine
- chinese herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title abstract description 6
- 201000011510 cancer Diseases 0.000 title description 9
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 5
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 241000411851 herbal medicine Species 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 4
- 241000218176 Corydalis Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 4
- 238000004080 punching Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000003398 Curcuma aromatica Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 244000131415 Zanthoxylum piperitum Species 0.000 abstract 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 abstract 1
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 241001522129 Pinellia Species 0.000 description 2
- 241001529739 Prunella <angiosperm> Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 201000005264 laryngeal carcinoma Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicinal preparation for treating various cancers and process for its preparation, wherein the preparation comprises a major medicament and a minor medicament, the main compositions of the major medicament are zedoary, artificial ox gallstone, andrographolide, tortoiseshell, and oldenlandia, the main compositions of the minor medicament are hairy vein agrimony, Chinese angelica root, notoginseng, zanthoxylum piperitum, Ligusticum wallichii, pilose asiabell root, and curcuma aromatica.
Description
The present invention relates to a kind of specific medicament that is used for the treatment of various cancers and preparation method thereof.
Cancer is one of present serious threat human life and healthy malignant disease, and cancer expert and knowledgeable people are controlled in the research of curing cancer drug in countries in the world, have spent a large amount of financial resources, material resources, can still not draw gratifying result.The various kinds of drug of existing treatment cancer, effect is not satisfactory, and in various degree deposit side effect.
The objective of the invention is for a kind of specific medicament for the treatment of cancer is provided.This medicine is divided into principal agent and auxiliary medicine (guiding drug), and is all formulated by Chinese medicine, has no side effect, and all kinds of cancers are had very outstanding treatment, alleviation and preventive effect.
In order to achieve the above object, drug main of the present invention will adopt, with malicious merit poison, liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, soothing the channels and quicking the network vessels, invigorating spleen to remove dampness, hard masses softening and resolving, heat-clearing and toxic substances removing, consolidate and set upright " principle, in treatment all kinds of cancers and clinical practice, obtained very obvious effects.
The combination ingredient and the configuration proportion thereof of principal agent medicine of the present invention following (calculating) by drug weight:
The Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 9 gram Rhizoma Curcumae 7 grams
Artificial Calculus Bovis's 12 gram punchings connect 7 grams
Carapax et Plastrum Testudinis 12 gram Rhizoma Coptidis 5 grams
Squama Manis 15 gram Herba Taraxacis 10 grams
The Herba Hedyotidis Diffusae 20 gram Rhizoma Atractylodis Macrocephalaes 10 grams
The Herba Scutellariae Barbatae 20 gram Rhizoma Pinelliaes 9 grams
The Herba Solani Nigri 20 gram Radix Rehmanniae 7 grams
Rhizoma Dioscoreae Bulbiferae 5 gram Spica Prunellaes 7 grams
Concha Ostreae 5 gram Rhizoma Corydalis 12 grams
Rhizoma sparganic 7 grams
The combination ingredient of auxiliary medicine (guiding drug) and configuration proportion thereof (calculating) by drug weight:
Herba Agrimoniae 15 gram Radix Angelicae Sinensis 10 grams
Radix Notoginseng 5 gram Fructus Zanthoxylis 5 grams
Rhizoma Chuanxiong 10 gram Radix Codonopsis 15 grams
Radix Curcumae 10 gram Pericarpium Citri Reticulataes 10 grams
Radix Bupleuri 15 grams
Embodiment
1, the preparation method of principal agent:
Principal agent of the present invention has 19 kinds of prepared from traditional Chinese medicines and forms, and gross weight is 199 grams, and wherein the weight of each composition is:
The Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 9 gram Rhizoma Curcumae 7 grams
Artificial Calculus Bovis's 12 gram punchings connect 7 grams
Carapax et Plastrum Testudinis 12 gram Rhizoma Coptidis 5 grams
Squama Manis 15 gram Herba Taraxacis 10 grams
The Herba Hedyotidis Diffusae 20 gram Rhizoma Atractylodis Macrocephalaes 10 grams
The Herba Scutellariae Barbatae 20 gram Rhizoma Pinelliaes 9 grams
The Herba Solani Nigri 20 gram Radix Rehmanniae 7 grams
Rhizoma Dioscoreae Bulbiferae 5 gram Spica Prunellaes 7 grams
Concha Ostreae 5 gram Rhizoma Corydalis 12 grams
Rhizoma sparganic 7 grams
Manufacture method: after above-mentioned every medicine pulverized in proportion and being ground into medicated powder, stir standby getting final product in the bottle of packing into.
2, the preparation method of auxiliary medicine (guiding drug):
Auxiliary medicine of the present invention (guiding drug) has 9 kinds of prepared from traditional Chinese medicines and forms, and gross weight is 95 grams, and wherein the weight of each composition is:
Herba Agrimoniae 15 gram Radix Angelicae Sinensis 10 grams
Radix Notoginseng 5 gram Fructus Zanthoxylis 5 grams
Rhizoma Chuanxiong 10 gram Radix Codonopsis 15 grams
Radix Curcumae 10 gram Pericarpium Citri Reticulataes 10 grams
Radix Bupleuri 15 grams
Manufacture method: above-mentioned 9 kinds of Chinese herbal medicine are proportioned, insert in the medicinal cupping, add four parts water again, boiled with the slow fire heating, it is standby to fry in shallow oil into medicinal liquid.
Instructions of taking: principal agent and auxiliary medicine (guiding drug) are simultaneously oral, take principal agent one soup ladle at every turn, and send down with decoction [auxiliary medicine (guiding drug)], can take every day three times.
In order to alleviate cancer patient's misery, reach aim of alleviating pain, when taking above-mentioned oral drugs, can use the pain relieving medicinal liquid to smear in patient's cancer lesion.
The manufacture method of external-use analgesic:
External-use analgesic has 5 kinds of prepared from traditional Chinese medicines to form, and gross weight is 26 grams, and wherein the weight of each composition is:
Olibanum 5 gram Myrrhas 5 grams
Borax 10 gram Radix Et Rhizoma Rhei 3 grams
Borneolum Syntheticum 3 grams
Manufacture method: earlier above-mentioned 5 kinds of Chinese medicines are mixed in proportion, place container, add the ethanol that 200 grams 70 are spent again in container, medicine soaks two days later in ethanol, promptly can be used for embrocating patient's sore spot (the part person of festering forbidding).
The medicine cost that the present invention uses is low, making is easy, evident in efficacy.Clinical trial certificate behind oral principal agent and auxiliary medicine (guiding drug), can reach more than 80% the total effective rate of diseases such as hepatocarcinoma, gastric cancer, intestinal cancer, pulmonary carcinoma, esophageal carcinoma, laryngeal carcinoma, breast carcinoma, lymphatic cancer, bladder cancer, cancer of pancreas.
Claims (5)
1, a kind of specific medicament that is used for the treatment of various cancers and preparation method thereof.It is characterized in that this medicine is formed by principal agent and two groups of Chinese medicine composition of auxiliary medicine (guiding drug), the composition of principal agent by: the Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae), Rhizoma Curcumae, artificial Calculus Bovis, punching company, Carapax et Plastrum Testudinis, Rhizoma Coptidis, Squama Manis, Herba Taraxaci, Herba Hedyotidis Diffusae, the Rhizoma Atractylodis Macrocephalae, Herba Scutellariae Barbatae, the Rhizoma Pinelliae, Herba Solani Nigri, the Radix Rehmanniae, Rhizoma Dioscoreae Bulbiferae, Spica Prunellae, Concha Ostreae, Rhizoma Corydalis, rhizoma sparganic are formed; The composition of auxiliary medicine (guiding drug) by: Herba Agrimoniae, Radix Angelicae Sinensis, Radix Notoginseng, Fructus Zanthoxyli, Rhizoma Chuanxiong, Radix Codonopsis, Radix Curcumae, Pericarpium Citri Reticulatae, Radix Bupleuri are formed.
2, Chinese herbal medicine according to claim 1 is characterized in that: the allocation ratio of principal agent is:
Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 1.5%-4.5% Rhizoma Curcumae 2%-3.5%
Artificial Calculus Bovis 0.5%-6% punching connects 0.5%-3.5%
Carapax et Plastrum Testudinis 0.5%-6% Rhizoma Coptidis 0.5%-2.5%
Squama Manis 0.5%-7.5% Herba Taraxaci 1%-5%
Herba Hedyotidis Diffusae 0.5%-10% Rhizoma Atractylodis Macrocephalae 1%-5%
Herba Scutellariae Barbatae 2%-10% Rhizoma Pinelliae 0.5%-4.5%
Herba Solani Nigri 2%-10% Radix Rehmanniae 0.5%-3.5%
Rhizoma Dioscoreae Bulbiferae 0.5%-2.5% Spica Prunellae 1.5%-3.5%
Concha Ostreae 0.5%-2.5% Rhizoma Corydalis 1%-6%
Rhizoma sparganic 2%-3.5%
3, Chinese herbal medicine according to claim 1 is characterized in that: the allocation ratio of auxiliary medicine (guiding drug) is:
Herba Agrimoniae 5%-15% Radix Angelicae Sinensis 5%-10%
Radix Notoginseng 1%-5% Fructus Zanthoxyli 1%-5%
Rhizoma Chuanxiong 5%-10% Radix Codonopsis 5%-15%
Radix Curcumae 5%-10% Pericarpium Citri Reticulatae 1%-10%
Radix Bupleuri 5%-15%
4, according to claim 1,2 described Chinese herbal medicine, the preparation method of its principal agent is: after the various Chinese herbal medicine that principal agent is used were pulverized according to the above ratio and are ground into medicated powder, stirring got final product.
5, Chinese herbal medicine according to claim 3, the preparation method of its auxiliary medicine (guiding drug) is: described Chinese herbal medicine proportioned, inserts in the medicinal cupping, add four parts water again, boiled with slow fire heating, fry in shallow oil into that medicinal liquid is standby to get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101213863A CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101213863A CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1546158A true CN1546158A (en) | 2004-11-17 |
| CN1274358C CN1274358C (en) | 2006-09-13 |
Family
ID=34338446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101213863A Expired - Fee Related CN1274358C (en) | 2003-12-16 | 2003-12-16 | Specific medicine for treating cancer and preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1274358C (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007080546A3 (en) * | 2006-01-11 | 2007-11-15 | Procter & Gamble | Compositions and methods useful for treatment of respiratory illness |
| CN100389748C (en) * | 2006-02-24 | 2008-05-28 | 陕西师范大学 | Chemotherapy emulsion for treating rectal cancer |
| CN101869667B (en) * | 2009-04-21 | 2011-07-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
| CN1943648B (en) * | 2006-10-18 | 2012-03-07 | 赵正福 | A plant medicine for treatment of primary hepatic carcinoma and its preparation method and use |
| CN101543612B (en) * | 2009-05-12 | 2012-07-04 | 王秋贤 | Chinese medicament for treating malignant lymphoma |
| CN102727854A (en) * | 2012-07-05 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN104383358A (en) * | 2014-11-03 | 2015-03-04 | 山东瑞康生命科技有限公司 | Preparation method of traditional Chinese medicine preparation for treating tongue cancer |
| CN104800510A (en) * | 2015-05-07 | 2015-07-29 | 王小华 | Traditional Chinese medicine composition for treating stomach cancer |
| CN105687664A (en) * | 2016-03-04 | 2016-06-22 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine condensed pill for treating head and neck neoplasms and preparation method thereof |
| CN109248236A (en) * | 2017-07-14 | 2019-01-22 | 浏阳市利美免疫力修复中心有限公司 | A kind of traditional Chinese medicine composition for treating liver tumor |
-
2003
- 2003-12-16 CN CNB2003101213863A patent/CN1274358C/en not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007080546A3 (en) * | 2006-01-11 | 2007-11-15 | Procter & Gamble | Compositions and methods useful for treatment of respiratory illness |
| CN100389748C (en) * | 2006-02-24 | 2008-05-28 | 陕西师范大学 | Chemotherapy emulsion for treating rectal cancer |
| CN1943648B (en) * | 2006-10-18 | 2012-03-07 | 赵正福 | A plant medicine for treatment of primary hepatic carcinoma and its preparation method and use |
| CN101869667B (en) * | 2009-04-21 | 2011-07-27 | 苏尔云 | Chinese herbal medicinal composition for treating lung cancer |
| CN101543612B (en) * | 2009-05-12 | 2012-07-04 | 王秋贤 | Chinese medicament for treating malignant lymphoma |
| CN102727854A (en) * | 2012-07-05 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN102727854B (en) * | 2012-07-05 | 2013-08-28 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN104383358A (en) * | 2014-11-03 | 2015-03-04 | 山东瑞康生命科技有限公司 | Preparation method of traditional Chinese medicine preparation for treating tongue cancer |
| CN104800510A (en) * | 2015-05-07 | 2015-07-29 | 王小华 | Traditional Chinese medicine composition for treating stomach cancer |
| CN105687664A (en) * | 2016-03-04 | 2016-06-22 | 上海交通大学医学院附属第九人民医院 | Traditional Chinese medicine condensed pill for treating head and neck neoplasms and preparation method thereof |
| CN109248236A (en) * | 2017-07-14 | 2019-01-22 | 浏阳市利美免疫力修复中心有限公司 | A kind of traditional Chinese medicine composition for treating liver tumor |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1274358C (en) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101987122B (en) | Medicine for relieving pain of human body and preparation method thereof | |
| CN101632737A (en) | Medicament for relieving pain of human body and preparation method thereof | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1336219A (en) | Gynopathy treating traditional Chinese medicine | |
| CN1274358C (en) | Specific medicine for treating cancer and preparing process | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1055638C (en) | Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1943683A (en) | An external use medicinel and beauty composition for treatment of and preventing chloasma | |
| CN101336998B (en) | A kind of traditional Chinese medicine for treating acne | |
| CN101036779A (en) | Composite medicine for treating hepatopathy and its preparing process | |
| CN1051471C (en) | A kind of pharmaceutical composition for treating osteoporosis | |
| CN100336547C (en) | Medicine for treating hypertension | |
| CN1111045C (en) | Chewing medicine for treating facial paralysis and its preparing process | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1589839A (en) | Stasis transforming pain relieving particle agent and its preparation method | |
| CN1074292C (en) | Cancer treating medicine capsule | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN1179953A (en) | Complete set of Chinese medicine preparations for curing hepatitis B | |
| CN1470271A (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1336221A (en) | Angiocardiopathy treating traditional Chinese medicine | |
| CN1144123A (en) | Prescription of Xinmaitai and its production process | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1463192A (en) | Herb compsns. for treating dopy and agrypnia | |
| CN1613475A (en) | Chinese medicine for treating liver diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060913 Termination date: 20101216 |